← Leaderboards
Jeffrey S Chamberlain
University Of Michigan At Ann Arbor
$54,800,495
Attributed
$56,431,807
Total exposure
24
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$75,328,459 · 26
By mechanism
R01$24,135,683 · 6
U54$20,764,050 · 7
P50$18,491,449 · 5
P01$6,747,856 · 5
R37$5,032,581 · 1
P51$156,634 · 1
Top collaborators
- Melissa Jan Spencer5 shared
- Niclas Emanuel Bengtsson1 shared
Others in their field
Top investigators on “Muscular Dystrophies”
- Stephen J. Tapscott · Fred Hutchinson Cancer Center$24,320,230
- Elizabeth M McNally · University Of Chicago$24,290,327
- Eric P Hoffman · Reveragen Biopharma, Inc.$24,157,975
- Charles A Thornton · Virginia Commonwealth University$22,039,420
- Krista H Vandenborne · University Of Pennsylvania$21,082,899
- Hugh Lee Sweeney · University Of Pennsylvania$20,945,683
Research focus
Muscular DystrophiesDystrophinMuscleGene TherapyVectorMicro-DystrophinGenesAdeno-Associated Viral VectorMediatingDesignGene DeliveryAnimalsAnimal ModelClinical TrialsMouse ModelResearch PersonnelMyocardiumProteinsBaseCanis FamiliarisGene TransferDuchenne Muscular DystrophyPhenotypeSkeletal Muscle
Grant awards (141)
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center - Seattle$1,642,472
P50 · FY2025 · AR · contact PI
Expression of dystrophins with enhanced function$671,240
R01 · FY2025 · AR · contact PI
Overcoming limitations for AAV gene therapy$670,615
P50 · FY2025 · AR · contact PI
Dystrophin Replacement$655,475
R01 · FY2025 · AR · contact PI
ADMIN CORE$105,885
P50 · FY2025 · AR · contact PI
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center - Seattle$1,674,346
P50 · FY2024 · AR · contact PI
Overcoming limitations for AAV gene therapy$669,685
P50 · FY2024 · AR · contact PI
Dystrophin Replacement$655,475
R01 · FY2024 · AR · contact PI
Optimizing and validation of gene therapy vectors to treat limb girdle muscular dystophy$481,106
R01 · FY2024 · NS
ADMIN CORE$105,738
P50 · FY2024 · AR · contact PI
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center - Seattle$1,746,547
P50 · FY2023 · AR · contact PI
Dystrophin Replacement$675,748
R01 · FY2023 · AR · contact PI
Overcoming limitations for AAV gene therapy$670,700
P50 · FY2023 · AR · contact PI
Optimizing and validation of gene therapy vectors to treat limb girdle muscular dystophy$495,985
R01 · FY2023 · NS
ADMIN CORE$105,898
P50 · FY2023 · AR · contact PI
Wellstone Muscular Dystrophy Specialized Research Center (Seattle)$1,538,665
P50 · FY2022 · AR · contact PI
Dystrophin Replacement$668,988
R01 · FY2022 · AR · contact PI
Project 1: Translational and pre-clinical studies of muscular dystrophy gene therapy using AAV$642,962
P50 · FY2022 · AR · contact PI
Optimizing and validation of gene therapy vectors to treat limb girdle muscular dystophy$496,020
R01 · FY2022 · NS
Administrative Core$77,750
P50 · FY2022 · AR · contact PI
Wellstone Muscular Dystrophy Specialized Research Center (Seattle)$1,518,858
P50 · FY2021 · AR · contact PI
Dystrophin Replacement$693,813
R01 · FY2021 · AR · contact PI
Project 1: Translational and pre-clinical studies of muscular dystrophy gene therapy using AAV$642,962
P50 · FY2021 · AR · contact PI
Optimizing and validation of gene therapy vectors to treat limb girdle muscular dystophy$552,804
R01 · FY2021 · NS
Assembly of the Dystrophin-Glycoprotein Complex$508,614
R01 · FY2021 · AR · contact PI
Administrative Core$77,750
P50 · FY2021 · AR · contact PI
Wellstone Muscular Dystrophy Specialized Research Center (Seattle)$1,540,834
P50 · FY2020 · AR · contact PI
Project 1: Translational and pre-clinical studies of muscular dystrophy gene therapy using AAV$642,962
P50 · FY2020 · AR · contact PI
Optimizing and validation of gene therapy vectors to treat limb girdle muscular dystophy$565,469
R01 · FY2020 · NS
Assembly of the Dystrophin-Glycoprotein Complex$524,344
R01 · FY2020 · AR · contact PI
Administrative Core$77,750
P50 · FY2020 · AR · contact PI
Wellstone Muscular Dystrophy Specialized Research Center (Seattle)$1,401,023
P50 · FY2019 · AR · contact PI
Project 1: Translational and pre-clinical studies of muscular dystrophy gene therapy using AAV$642,962
P50 · FY2019 · AR · contact PI
Dystrophin Replacement$576,032
R01 · FY2019 · AR · contact PI
Assembly of the Dystrophin-Glycoprotein Complex$524,344
R01 · FY2019 · AR · contact PI
Administrative Core$77,750
P50 · FY2019 · AR · contact PI
Wellstone Muscular Dystrophy Specialized Research Center (Seattle)$1,497,307
P50 · FY2018 · AR · contact PI
Project 1: Translational and pre-clinical studies of muscular dystrophy gene therapy using AAV$642,278
P50 · FY2018 · AR · contact PI
Dystrophin Replacement$576,032
R01 · FY2018 · AR · contact PI
Assembly of the Dystrophin-Glycoprotein Complex$523,923
R01 · FY2018 · AR · contact PI
Therapeutic potential for AAV/micro-dystrophin transfer to cardiopulmonary tissue$503,928
R01 · FY2018 · HL · contact PI
Administrative Core$77,750
P50 · FY2018 · AR · contact PI
Sen Paul D. Wellstone Muscular Dystrophy Cooperative Research Center: Seattle$1,560,721
U54 · FY2017 · AR · contact PI
Translational and pre-clinical studies of AAV-mediated gene therapy of muscular$690,622
U54 · FY2017 · AR · contact PI
Dystrophin Replacement$576,032
R01 · FY2017 · AR · contact PI
Assembly of the Dystrophin-Glycoprotein Complex$522,237
R01 · FY2017 · AR · contact PI
Therapeutic potential for AAV/micro-dystrophin transfer to cardiopulmonary tissue$503,928
R01 · FY2017 · HL · contact PI
Muscular dystrophy clinical trial foundations$468,963
U54 · FY2017 · AR · contact PI
Vector Research Resource Core$165,315
U54 · FY2017 · AR · contact PI
Investigator Development Core$158,571
U54 · FY2017 · AR · contact PI
Administrative$77,250
U54 · FY2017 · AR · contact PI
Sen Paul D. Wellstone Muscular Dystrophy Cooperative Research Center: Seattle$1,567,752
U54 · FY2016 · AR · contact PI
Translational and pre-clinical studies of AAV-mediated gene therapy of muscular$708,343
U54 · FY2016 · AR · contact PI
Dystrophin Replacement$576,032
R01 · FY2016 · AR · contact PI
Muscular dystrophy clinical trial foundations$516,491
U54 · FY2016 · AR · contact PI
Therapeutic potential for AAV/micro-dystrophin transfer to cardiopulmonary tissue$503,928
R01 · FY2016 · HL · contact PI
Assembly of the Dystrophin-Glycoprotein Complex$445,515
R01 · FY2016 · AR · contact PI
Vector Research Resource Core$175,391
U54 · FY2016 · AR · contact PI
Investigator Development Core$167,527
U54 · FY2016 · AR · contact PI
Sen Paul D. Wellstone Muscular Dystrophy Cooperative Research Center: Seattle$1,574,098
U54 · FY2015 · AR · contact PI
Translational and pre-clinical studies of AAV-mediated gene therapy of muscular$740,047
U54 · FY2015 · AR · contact PI
Dystrophin Replacement$576,032
R01 · FY2015 · AR · contact PI
Therapeutic potential for AAV/micro-dystrophin transfer to cardiopulmonary tissue$503,928
R01 · FY2015 · HL · contact PI
Muscular dystrophy clinical trial foundations$491,200
U54 · FY2015 · AR · contact PI
Assembly of the Dystrophin-Glycoprotein Complex$445,515
R01 · FY2015 · AR · contact PI
Vector Research Resource Core$175,358
U54 · FY2015 · AR · contact PI
Investigator Development Core$167,493
U54 · FY2015 · AR · contact PI
Sen Paul D. Wellstone Muscular Dystrophy Cooperative Research Center: Seattle$1,634,029
U54 · FY2014 · AR · contact PI
Translational and pre-clinical studies of AAV-mediated gene therapy of muscular$764,796
U54 · FY2014 · AR · contact PI
Muscular dystrophy clinical trial foundations$524,739
U54 · FY2014 · AR · contact PI
Dystrophin Replacement in mdx mice$515,606
R37 · FY2014 · AR · contact PI
Assembly of the Dystrophin-Glycoprotein Complex$436,605
R01 · FY2014 · AR · contact PI
Investigator Development Core$181,502
U54 · FY2014 · AR · contact PI
Vector Research Resource Core$162,992
U54 · FY2014 · AR · contact PI
Dystrophin Replacement in mdx mice$499,822
R37 · FY2013 · AR · contact PI
Assembly of the Dystrophin-Glycoprotein Complex$429,139
R01 · FY2013 · AR · contact PI
Genetic modification of aging and diseased striated muscle$370,215
R01 · FY2013 · AG · contact PI
DYSTROPHIN DELIVERY TO MUSCLE VIA MYOGENIC PRECURSORS$267,135
P01 · FY2013 · NS · contact PI
Mouse Physiology Core$39,504
P01 · FY2013 · NS · contact PI
Dystrophin Replacement in mdx mice$526,129
R37 · FY2012 · AR · contact PI
Assembly of the Dystrophin-Glycoprotein Complex$450,633
R01 · FY2012 · AR · contact PI
Genetic modification of aging and diseased striated muscle$391,763
R01 · FY2012 · AG · contact PI
DYSTROPHIN DELIVERY TO MUSCLE VIA MYOGENIC PRECURSORS$280,839
P01 · FY2012 · NS · contact PI
Mouse Physiology Core$40,614
P01 · FY2012 · NS · contact PI
Dystrophin Replacement in mdx mice$526,129
R37 · FY2011 · AR · contact PI
Genetic modification of aging and diseased striated muscle$391,764
R01 · FY2011 · AG · contact PI
Assembly of the Dystrophin-Glycoprotein Complex$312,388
R01 · FY2011 · AR · contact PI
DYSTROPHIN DELIVERY TO MUSCLE VIA MYOGENIC PRECURSORS$284,877
P01 · FY2011 · NS · contact PI
SYSTEMIC GENE TRANSFER IN NON-HUMAN PRIMATES VIA RAAV6$156,634
P51 · FY2011 · RR · contact PI
Mouse Physiology Core$40,295
P01 · FY2011 · NS · contact PI
Dystrophin Replacement in mdx mice$554,542
R37 · FY2010 · AR · contact PI
Genetic modification of aging and diseased striated muscle$395,721
R01 · FY2010 · AG · contact PI
Assembly of the Dystrophin-Glycoprotein Complex$325,405
R01 · FY2010 · AR · contact PI
DYSTROPHIN DELIVERY TO MUSCLE VIA MYOGENIC PRECURSORS$288,867
P01 · FY2010 · NS · contact PI
Mouse Physiology Core$39,967
P01 · FY2010 · NS · contact PI
Dystrophin Replacement in mdx mice$515,962
R37 · FY2009 · AR · contact PI
Genetic modification of aging and diseased striated muscle$388,075
R01 · FY2009 · AG · contact PI
Assembly of the Dystrophin-Glycoprotein Complex$328,692
R01 · FY2009 · AR · contact PI
DYSTROPHIN DELIVERY TO MUSCLE VIA MYOGENIC PRECURSORS$285,350
P01 · FY2009 · NS · contact PI
Mouse Physiology Core$72,066
P01 · FY2009 · NS · contact PI
Dystrophin Delivery to Muscle via Myogenic Precursors$610,728
P01 · FY2008 · NS · contact PI
Dystrophin Replacement in mdx mice$504,779
R37 · FY2008 · AR · contact PI
Assembly of the Dystrophin-Glycoprotein Complex$328,692
R01 · FY2008 · AR · contact PI
Core--Mouse Biology$84,886
P01 · FY2008 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$1,341,899
U54 · FY2007 · HD · contact PI
Dystrophin Delivery to Muscle via Myogenic Precursors$625,696
P01 · FY2007 · NS · contact PI
Dystrophin Replacement in mdx mice$477,161
R37 · FY2007 · AR · contact PI
IMPROVED VIRAL VECTORS FOR GENE TRANSFER TO MUSCLE$410,950
P01 · FY2007 · AG · contact PI
Assembly of the Dystrophin-Glycoprotein Complex$335,131
R01 · FY2007 · AR · contact PI
Core--Mouse Biology$86,987
P01 · FY2007 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$1,837,343
U54 · FY2006 · HD · contact PI
Dystrophin Delivery to Muscle via Myogenic Precursors$648,012
P01 · FY2006 · NS · contact PI
Dystrophin Replacement in mdx mice$459,439
R37 · FY2006 · AR · contact PI
IMPROVED VIRAL VECTORS FOR GENE TRANSFER TO MUSCLE$392,885
P01 · FY2006 · AG · contact PI
Assembly of the dystrophin associated protein complex$331,234
R01 · FY2006 · AR · contact PI
Core--Mouse Biology$89,872
P01 · FY2006 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$2,138,393
U54 · FY2005 · HD
Dystrophin Delivery to Muscle via Myogenic Precursors$648,702
P01 · FY2005 · NS
Dystrophin Replacement in mdx mice$453,012
R37 · FY2005 · AR
Assembly of the dystrophin associated protein complex$339,205
R01 · FY2005 · AR
Core--Mouse Biology$89,872
P01 · FY2005 · NS
Muscular Dystrophy Cooperative Research Center$1,381,977
U54 · FY2004 · HD
Dystrophin Delivery to Muscle via Myogenic Precursors$663,019
P01 · FY2004 · NS
DYSTROPHIN REPLACEMENT IN MDX MICE$368,600
R01 · FY2004 · AR
Assembly of the dystrophin associated protein complex$367,630
R01 · FY2004 · AR
Core--Mouse Biology$89,872
P01 · FY2004 · NS
Muscular Dystrophy Cooperative Research Center$1,391,238
U54 · FY2003 · HD
DYSTROPHIN REPLACEMENT IN MDX MICE$368,600
R01 · FY2003 · AR
Assembly of the dystrophin associated protein complex$367,630
R01 · FY2003 · AR
DYSTROPHIN REPLACEMENT IN MDX MICE$368,600
R01 · FY2002 · AR
Assembly of the dystrophin associated protein complex$368,600
R01 · FY2002 · AR
MODIFIED ADENOVIRAL VECTORS FOR GENE TRANSFER TO MUSCLE$254,615
P01 · FY2002 · AG
DYSTROPHIN REPLACEMENT IN MDX MICE$368,600
R01 · FY2001 · AR
ASSEMBLY OF THE DSYTROPHIN ASSOCIATED PROTEIN COMPLEX$326,691
R01 · FY2001 · AR
MODIFIED ADENOVIRAL VECTORS FOR GENE TRANSFER TO MUSCLE$254,615
P01 · FY2001 · AG
DYSTROPHIN REPLACEMENT IN MDX MICE$248,550
R01 · FY2000 · AR
ASSEMBLY OF THE DSYTROPHIN ASSOCIATED PROTEIN COMPLEX$186,482
R01 · FY2000 · AR
MODIFIED ADENOVIRAL VECTORS FOR GENE TRANSFER TO MUSCLE$157,631
P01 · FY2000 · AG
ASSEMBLY OF THE DSYTROPHIN ASSOCIATED PROTEIN COMPLEX$126,421
R01 · FY2000 · AR
DYSTROPHIN REPLACEMENT IN MDX MICE$112,130
R01 · FY2000 · AR
SEQUENCE ANALYSIS OF MICROSATELLITE REPEATS$206
M01 · FY2000 · RR